U.S. flag

An official website of the United States government

NM_004562.3(PRKN):c.98G>A (p.Arg33Gln) AND not provided

Germline classification:
Pathogenic/Likely pathogenic (3 submissions)
Last evaluated:
Jan 17, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001090784.34

Allele description [Variation Report for NM_004562.3(PRKN):c.98G>A (p.Arg33Gln)]

NM_004562.3(PRKN):c.98G>A (p.Arg33Gln)

Gene:
PRKN:parkin RBR E3 ubiquitin protein ligase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
6q26
Genomic location:
Preferred name:
NM_004562.3(PRKN):c.98G>A (p.Arg33Gln)
HGVS:
  • NC_000006.12:g.162443383C>T
  • NG_008289.2:g.289420G>A
  • NM_004562.3:c.98G>AMANE SELECT
  • NM_013987.3:c.98G>A
  • NM_013988.3:c.98G>A
  • NP_004553.2:p.Arg33Gln
  • NP_054642.2:p.Arg33Gln
  • NP_054643.2:p.Arg33Gln
  • NC_000006.11:g.162864415C>T
  • NM_004562.2:c.98G>A
Protein change:
R33Q
Links:
dbSNP: rs147757966
NCBI 1000 Genomes Browser:
rs147757966
Molecular consequence:
  • NM_004562.3:c.98G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_013987.3:c.98G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_013988.3:c.98G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
2

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001246506CeGaT Center for Human Genetics Tuebingen
criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)
Pathogenic
(May 1, 2019)
germlineclinical testing

Citation Link,

SCV001584588Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jan 17, 2024)
germlineclinical testing

PubMed (11)
[See all records that cite these PMIDs]

SCV002502335AiLife Diagnostics, AiLife Diagnostics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Sep 10, 2021)
germlineclinical testing

PubMed (9)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes2not providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early-onset Parkinson's Disease.

Hertz JM, Ostergaard K, Juncker I, Pedersen S, Romstad A, Møller LB, Güttler F, Dupont E.

Eur J Neurol. 2006 Apr;13(4):385-90.

PubMed [citation]
PMID:
16643317

Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations.

Pankratz N, Kissell DK, Pauciulo MW, Halter CA, Rudolph A, Pfeiffer RF, Marder KS, Foroud T, Nichols WC; Parkinson Study Group-PROGENI Investigators..

Neurology. 2009 Jul 28;73(4):279-86. doi: 10.1212/WNL.0b013e3181af7a33.

PubMed [citation]
PMID:
19636047
PMCID:
PMC2715211
See all PubMed Citations (16)

Details of each submission

From CeGaT Center for Human Genetics Tuebingen, SCV001246506.26

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001584588.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (11)

Description

This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 33 of the PRKN protein (p.Arg33Gln). This variant is present in population databases (rs147757966, gnomAD 0.02%). This missense change has been observed in individuals with early-onset Parkinson disease (PMID: 12730996, 16643317, 19636047). It has also been observed to segregate with disease in related individuals. This variant is also known as 199G>A. ClinVar contains an entry for this variant (Variation ID: 578186). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Experimental studies have shown that this missense change affects PRKN function (PMID: 15606901, 21348451, 21694720, 23770917, 24647965, 26631732, 27534820). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From AiLife Diagnostics, AiLife Diagnostics, SCV002502335.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (9)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Oct 26, 2024